Miliary tuberculosis medical therapy
|
Miliary tuberculosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Miliary tuberculosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Miliary tuberculosis medical therapy |
|
Risk calculators and risk factors for Miliary tuberculosis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Medical Therapy
Miliary TB is a serious condition; untreated miliary TB is almost always fatal. About 25% of patients with miliary TB also have tuberculous meningitis. The standard treatment recommended by the WHO is with isoniazid and rifampicin for six months, as well as ethambutol and pyrazinamide for the first two months. If there is evidence of meningitis, then treatment is extended to twelve months. The US guidelines recommend nine months of treatment. Common medication side effects a patient may have such as inflammation of the liver if a patient is taking pyrazinamide, rifampin, and isoniazid. A patient may also have drug resistance to medication, relapse, respiratory failure, and adult Respiratory Distress Syndrome[1]
References
- ↑ Dugdale, David, "Disseminated Tuberculosis" http://www.nlm.nih.gov/medlineplus/ency/article/000624htm, December 3, 2008.